Delivery Order SPE2DR25D3016-SPE2DR26FG3DN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,319.99 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-unit supply) with a firm fixed price arrangement. This non-set-aside contract was competitively awarded on November 14, 2025, with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of XCOPRI 200 mg tablets (30-count units) valued at $2,127.24. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,768.44, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded delivery order was issued on August 19, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- This is a $1,655.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a period of performance through July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 200 MG tablets (30-count) on October 22, 2025, with completion targeted for October 23, 2025. This competitively awarded, firm fixed-price contract involves performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among qualified pharmaceutical distributors to support federal medical...
- The Defense Logistics Agency awarded a $1,768.44 delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed price contract type. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.38 to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count packaging) on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. XCOPRI is a prescription medication used in the treatment of seizure disorders,...
- The Defense Logistics Agency awarded a $3,646.82 delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of XCOPRI 100 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by May 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count package) valued at $1,277.60 under a firm fixed-price contract type. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract, consistent with the...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG3DNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,377.63 to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count package) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. This contract structure allows Cencora/AmerisourceBergen to efficiently fulfill government requirements for essential pharmaceuticals and medical commodities across multiple therapeutic domains for military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/8/26 |